Medicare Enrolled

Dr. George Cheeseman, MD

Family Medicine · Riverview, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
7229 US HIGHWAY 301 S, Riverview, FL 33578
8136778418
In practice since 2006 (19 years)
NPI: 1912961269 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cheeseman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheeseman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cheeseman

Dr. George Cheeseman is a family medicine in Riverview, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cheeseman performed 508 Medicare services across 294 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cheeseman received a total of $22,639 from 71 pharmaceutical and/or device companies across 1347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cheeseman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 508 Medicare services$ $22,639 industry payments

Medicare Practice Summary

Medicare Utilization ↗
508
Medicare services
Bottom 45% in FL for family medicine
294
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)296$89$273
Annual wellness visit, follow-up53$126$291
Office visit, established patient (20-29 min)43$65$186
Flu vaccine, high-dose31$70$184
Flu vaccine administration31$30$74
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use20$268$662
Pneumonia vaccine administration19$30$74
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza15$66$184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,639
Total received (2018-2024)
Avg $3,234/year across 7 years
Top 1% in FL for family medicine
71
Companies
1,347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,502 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,704
2023
$3,057
2022
$3,237
2021
$4,048
2020
$3,160
2019
$2,740
2018
$3,693

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,822
Lilly USA, LLC
$1,965
Novo Nordisk Inc
$1,620
Amarin Pharma Inc.
$1,601
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,178
PFIZER INC.
$1,157
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,044
Amgen Inc.
$999
Lucid Diagnostics Inc.
$714
AbbVie Inc.
$705
Kowa Pharmaceuticals America, Inc.
$613
Merck Sharp & Dohme Corporation
$542
Janssen Pharmaceuticals, Inc
$541
Abbott Laboratories
$513
GlaxoSmithKline, LLC.
$447
ABBVIE INC.
$420
Mylan Specialty L.P.
$374
SANOFI-AVENTIS U.S. LLC
$357
Astellas Pharma US Inc
$340
Esperion Therapeutics, Inc.
$323
Bayer Healthcare Pharmaceuticals Inc.
$308
Merck Sharp & Dohme LLC
$273
Novartis Pharmaceuticals Corporation
$262
AbbVie, Inc.
$244
Vanda Pharmaceuticals Inc.
$244
Allergan, Inc.
$232
Exact Sciences Corporation
$231
Bayer HealthCare Pharmaceuticals Inc.
$188
Biohaven Pharmaceutical Holding Company Ltd.
$182
Radius Health, Inc.
$168
ARBOR PHARMACEUTICALS, INC.
$154
IDORSIA PHARMACEUTICALS US INC
$142
Horizon Therapeutics plc
$134
Sumitomo Pharma America, Inc.
$124
Eisai Inc.
$117
Allergan Inc.
$114
Dexcom, Inc.
$98
Paratek Pharmaceuticals, Inc.
$82
Phathom Pharmaceuticals, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$72
QOL Medical, LLC
$62
Azurity Pharmaceuticals, Inc.
$61
E.R. Squibb & Sons, L.L.C.
$59
Biohaven Pharmaceuticals, Inc.
$53
Teva Pharmaceuticals USA, Inc.
$45
VistaPharm, Inc.
$43
Sanofi Pasteur Inc.
$39
JAZZ PHARMACEUTICALS INC.
$38
Intercept Pharmaceuticals, Inc.
$36
Nestle HealthCare Nutrition Inc.
$36
CeQur Corporation
$34
Genentech USA, Inc.
$34
Arbor Pharmaceuticals, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$30
Dynavax Technologies Corporation
$29
Hologic Sales and Service, LLC
$26
SHIELD THERAPEUTICS INC
$25
Phadia US Inc.
$24
OptiNose US, Inc.
$22
Corcept Therapeutics
$21
Daiichi Sankyo Inc.
$20
Nabriva Therapeutics, plc
$18
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Otsuka America Pharmaceutical, Inc.
$15
EISAI INC.
$15
AMAG Pharmaceuticals, Inc.
$15
Kyowa Kirin, Inc.
$15
Nevro Corp.
$15
VIVUS LLC
$14
Tactile Systems Technology Inc
$14
Noden Pharma USA Inc
$13
Top 3 companies account for 28.3% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · APTIMA · AREXVY · Accent Pacemaker · Aduhelm · Aimovig · Assurity Pacemaker · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · CeQur Simplicity · Cologuard Collection Kit · Creon · Crysvita · DUEXIS · Dayvigo · Dexcom G6 Transmitter · Dexilant · Dymista · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flexitouch Plus · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GEMTESA · HETLIOZ · Heplisav-B · Horizant · INJECTAFER · INTRAROSA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LILETTA · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Mitra Clip system · Myrbetriq · NEXLETOL · NEXLIZET · NURTEC ODT · NUZYRA · OCALIVA · OFEV · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRADAXA · PRALUENT · PREMARIN · PREVNAR 13 · PREVNAR 20 · Proclaim Family of SCS IPGs · Prolia · QULIPTA · QUVIVIQ · Qsymia · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUCRAID · SUNOSI · SYMBICORT · SYNTHROID · Saxenda · Seglentis · Senza · Sivextro · Synthroid · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thyquidity · Tresiba · Tymlos · UBRELVY · VERQUVO · VESICARE · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · VYNDAMAX · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xhance · Xofluza · Xultophy 100/3.6 · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in FL.

Equivalent to $4,457 per 100 Medicare services performed
Looking for a family medicine in Riverview?
Compare family medicines in the Riverview area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
921
Per 100K population
61.8
County median income
$75,011
Nearest hospital
ADVENTHEALTH RIVERVIEW
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cheeseman is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cheeseman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cheeseman performed 296 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheeseman receive payments from pharmaceutical companies?
Yes. Dr. Cheeseman received a total of $22,639 from 71 companies across 1,347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheeseman's costs compare to other family medicines in Riverview?
Dr. Cheeseman's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheeseman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →